Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Blood Thinning Drug Aids Understanding of Natural HIV Barrier

March 24, 2015 8:50 am | by University of East Anglia | News | Comments

A blood thinning agent is helping researchers understand more about the body’s natural barriers to HIV. Read more...


Scientists Use DNA Sequencing to Trace Spread of Drug Resistant TB

March 24, 2015 8:45 am | by Sam Wong, Imperial College London | News | Comments

Scientists have for the first time used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis between patients in the UK. Read more...


WHO Denies Politics Swayed Ebola Emergency Declaration

March 24, 2015 8:40 am | by Maria Cheng and Raphael Satter, Associated Press | News | Comments

The World Health Organization denied Monday that politics swayed the decision to declare an international emergency over the spread of the Ebola virus last year. Read more...


Neovacs Launches American Subsidiary in Boston

March 24, 2015 8:36 am | News | Comments

Neovacs will be located in Boston within the French Tech Hub. Read more...


Mutated Gene Increases Insulin Resistance

March 24, 2015 8:31 am | by Becky Bach, Stanford University | News | Comments

An international team of researchers at the Stanford has discovered a gene that, when mutated, increases insulin resistance. Read more...


Blood Test for Patients on Acne Medication Deemed Unnecessary

March 23, 2015 10:58 am | by Brigham and Women's Hospital | News | Comments

A new study by researchers at Brigham and Women's Hospital (BWH) has found that for young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care expense. Read more...


Potential Drug Target for Protection against Neurodegenerative Diseases

March 23, 2015 10:39 am | by UPenn | News | Comments

Penn Medicine researchers have discovered that hypermethylation - the epigenetic ability to turn down or turn off a bad gene implicated in 10 to 30 percent of patients with Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Degeneration (FTD) - serves as a protective barrier inhibiting the development of these diseases. Read more...

Scientists Win $1.5 Million Grant to Develop New Cancer Drugs

March 23, 2015 10:14 am | by Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded a $1.5 million grant from the National Institutes of Health (NIH) to develop drug candidates that could treat cancer and neurodegenerative disease. Read more..


Small Cellular Changes Research May Lead to Cancer Solutions

March 23, 2015 10:05 am | by University of Colorado | News | Comments

Among cancers, scientists have spent their entire research careers looking for cellular similarities that may lead to a single cure for many cancers –– the rare chance to have a single answer to a multifaceted problem. Read more...

Cloud Pharmaceuticals, UF Collaborate on Design of Novel Cancer Inhibitors

March 23, 2015 9:59 am | News | Comments

Cloud Pharmaceuticals, a therapeutics company focused on cloud-based drug design and development, and the University of Florida Department of Medicine have announced an academic collaboration that will help rapidly design and develop novel drugs to inhibit the reproduction of cancer cells. Read more...


Google Teams With MIT, Harvard for Genetics Research Project

March 23, 2015 9:57 am | by Ryan Bushey, Associate Editor | Articles | Comments

The goal of this partnership is to find treatments for aging related diseases. Read more...


New Test to Revolutionize Disease Detection in People, Crops, and Stock

March 23, 2015 8:43 am | by University of Queensland | News | Comments

A single-drop DNA test invented by scientists could revolutionize the detection of diseases in humans, livestock and crops. Read more...


Novartis' Cosentyx Shows Sustained Effect and Favorable Safety Profile

March 23, 2015 8:35 am | News | Comments

Novartis announced new two-year results demonstrating strong and sustained efficacy with Cosentyx. Read more...


Biogen: Positive Phase 1 Results for Alzheimer's Drug

March 23, 2015 8:26 am | News | Comments

Treatment with the drug produced a dose and time dependent reduction of amyloid plaque in the brain. Read more...


New Hopes for Rheumatic Fever Vaccine

March 23, 2015 8:26 am | by University of Auckland | News | Comments

A new vaccine to combat the debilitating disease caused by rheumatic fever may soon become a reality, saving hundreds of thousands of deaths from preventable heart disease around the world each year. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.